Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Clinical characterization and outcomes of 85 patients with neurosarcoidosis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • Corporate Authors:
      SarcoGEAS-SEMI Registry
    • المصدر:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • الموضوع:
      Brain/*pathology ; Central Nervous System/*pathology ; Central Nervous System Diseases/*diagnosis ; Peripheral Nerves/*pathology ; Sarcoidosis/*diagnosis; Adult ; Aged ; Central Nervous System/diagnostic imaging ; Central Nervous System Diseases/classification ; Central Nervous System Diseases/pathology ; Cohort Studies ; Cranial Nerves/pathology ; Female ; Humans ; Male ; Meninges/pathology ; Middle Aged ; Sarcoidosis/classification ; Sarcoidosis/complications ; Sarcoidosis/pathology ; Spinal Cord/pathology
    • نبذة مختصرة :
      To analyze the frequency and clinical phenotype of neurosarcoidosis (NS) in one of the largest nationwide cohorts of patients with sarcoidosis reported from southern Europe. NS was evaluated according to the Diagnostic Criteria for Central Nervous System and Peripheral Nervous System Sarcoidosis recently proposed by Stern et al. Pathologic confirmation of granulomatous disease was used to subclassify NS into definite (confirmation in neurological tissue), probable (confirmation in extraneurological tissue) and possible (no histopathological confirmation of the disease). Of the 1532 patients included in the cohort, 85 (5.5%) fulfilled the Stern criteria for NS (49 women, mean age at diagnosis of NS of 47.6 years, 91% White). These patients developed 103 neurological conditions involving the brain (38%), cranial nerves (36%), the meninges (3%), the spinal cord (10%) and the peripheral nerves (14%); no patient had concomitant central and peripheral nerve involvements. In 59 (69%) patients, neurological involvement preceded or was present at the time of diagnosis of the disease. According to the classification proposed by Stern et al., 11 (13%) were classified as a definite NS, 61 (72%) as a probable NS and the remaining 13 (15%) as a possible NS. In comparison with the systemic phenotype of patients without NS, patients with CNS involvement presented a lower frequency of thoracic involvement (82% vs 93%, q = 0.018), a higher frequency of ocular (27% vs 10%, q < 0.001) and salivary gland (15% vs 4%, q = 0.002) WASOG involvements. In contrast, patients with PNS involvement showed a higher frequency of liver involvement (36% vs 12%, p = 0.02) in comparison with patients without NS. Neurosarcoidosis was identified in 5.5% of patients. CNS involvement prevails significantly over PNS involvement, and both conditions do not overlap in any patient. The systemic phenotype associated to each involvement was clearly differentiated, and can be helpful not only in the early identification of neurological involvement, but also in the systemic evaluation of patients diagnosed with neurosarcoidosis.
    • References:
      Br Med J. 1961 Nov 4;2(5261):1165-72. (PMID: 14497750)
      Eur Respir J. 2008 Feb;31(2):372-9. (PMID: 17959635)
      Eur J Intern Med. 2019 Nov;69:77-85. (PMID: 31521474)
      Medicine (Baltimore). 2016 Apr;95(14):e3277. (PMID: 27057889)
      QJM. 2009 Jul;102(7):449-60. (PMID: 19383611)
      Ann Neurol. 2016 Mar;79(3):437-47. (PMID: 26677112)
      Lancet. 2003 Mar 29;361(9363):1111-8. (PMID: 12672326)
      Lancet. 2002 Jun 15;359(9323):2085-6. (PMID: 12086764)
      Clin Exp Rheumatol. 2016 May-Jun;34(3):380-8. (PMID: 27050339)
      J Neurol. 2016 May;263(5):981-990. (PMID: 27007482)
      Neurologist. 2012 Nov;18(6):373-7. (PMID: 23114669)
      QJM. 1999 Feb;92(2):103-17. (PMID: 10209662)
      Ann Am Thorac Soc. 2016 Aug;13(8):1244-52. (PMID: 27509154)
      Am J Ophthalmol. 1984 Jan;97(1):62-77. (PMID: 6696022)
      Sarcoidosis Vasc Diffuse Lung Dis. 2016 Oct 07;33(3):209-215. (PMID: 27758985)
      Respir Med. 2017 May;126:135-138. (PMID: 28318820)
      JAMA Neurol. 2018 Dec 1;75(12):1546-1553. (PMID: 30167654)
      Pract Neurol. 2007 Aug;7(4):234-44. (PMID: 17636138)
      Neurol Res. 1993 Dec;15(6):389-90. (PMID: 7907406)
      J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):297-304. (PMID: 18977817)
      Med Klin (Munich). 2000 Oct 15;95(10):583-6. (PMID: 11092172)
      Clin Exp Rheumatol. 2013 Jan-Feb;31(1):103-10. (PMID: 23020902)
      Chest. 1997 Jul;112(1):220-8. (PMID: 9228380)
      Neurology. 2017 Nov 14;89(20):2092-2100. (PMID: 29030454)
      Eur Respir J. 2018 Jan 25;51(1):. (PMID: 29371378)
      Neurology. 1991 Oct;41(10):1558-61. (PMID: 1656324)
      Brain. 2002 Feb;125(Pt 2):264-75. (PMID: 11844727)
      BMC Neurol. 2016 Nov 15;16(1):220. (PMID: 27846819)
      AJNR Am J Neuroradiol. 2009 May;30(5):953-61. (PMID: 19193748)
      Sarcoidosis Vasc Diffuse Lung Dis. 1999 Sep;16(2):149-73. (PMID: 10560120)
      Eur J Neurol. 2013 Jan;20(1):71-8. (PMID: 22681045)
      Mayo Clin Proc. 2016 Feb;91(2):183-8. (PMID: 26727158)
      Curr Opin Pulm Med. 2014 Sep;20(5):496-502. (PMID: 25035964)
      J Neurol. 2018 Aug;265(8):1906-1915. (PMID: 29922952)
      J Neurol Neurosurg Psychiatry. 1986 Jul;49(7):756-63. (PMID: 3746306)
      Pituitary. 2016 Feb;19(1):19-29. (PMID: 26267304)
      J Neurol. 2006 Apr;253(4):488-95. (PMID: 16283095)
      Sarcoidosis Vasc Diffuse Lung Dis. 2006 Mar;23(1):58-65. (PMID: 16933471)
      Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):119-27. (PMID: 23461074)
      Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):19-27. (PMID: 24751450)
      Neurologist. 2010 Nov;16(6):386-9. (PMID: 21150390)
      Arthritis Rheumatol. 2020 Jan;72(1):67-77. (PMID: 31390162)
      AJNR Am J Neuroradiol. 1999 Apr;20(4):655-69. (PMID: 10319978)
      J Neurol. 2015 Feb;262(2):258-67. (PMID: 25194844)
      Innov Clin Neurosci. 2012 Apr;9(4):10-6. (PMID: 22666636)
      Clin Exp Rheumatol. 2019 Nov-Dec;37(6):1052-1064. (PMID: 31498063)
      Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1885-9. (PMID: 11734441)
      Arch Neurol. 1995 Sep;52(9):875-9. (PMID: 7661724)
      Curr Opin Pulm Med. 2014 Sep;20(5):472-8. (PMID: 25029298)
      Rev Neurol (Paris). 2000 Nov;156(11):965-75. (PMID: 11119048)
      Rinsho Shinkeigaku. 2005 Nov;45(11):837-40. (PMID: 16447740)
      Handb Clin Neurol. 2014;119:305-33. (PMID: 24365304)
      Am J Med Sci. 2014 Mar;347(3):195-8. (PMID: 23364469)
      Eur J Intern Med. 2011 Dec;22(6):e125-32. (PMID: 22075297)
      Medicine (Baltimore). 2010 Mar;89(2):133-140. (PMID: 20517184)
      Semin Neurol. 2014 Sep;34(4):386-94. (PMID: 25369434)
    • Contributed Indexing:
      Investigator: M Ramos-Casals; R Pérez-Alvarez; B Kostov; R Gómez-de-la-Torre; C Feijoo-Massó; J Chara-Cervantes; B Pinilla; A González-García; JS Garcia-Morillo; M López-Dupla; B De-Escalante; J Rascón; P Perez-Guerrero; M Bonet; G Cruz-Caparrós; A Alguacil; JL Callejas; E Calvo; C Soler; A Robles; B de Miguel-Campo; P Oliva-Nacarino; J Estela-Herrero; L Pallarés; P Brito-Zerón; Y Blanco; M Pérez-Conesa; E Fonseca-Aizpuru; M Akasbi; G De-la-Red; E Peral-Gutiérrez; JF Gómez-Cerezo; S Rodríguez-Fernández; A Gato; AJ Chamorro; C Morcillo; I Ojeda; MJ Vives; M Penadés; M De-Vicente; X Bosch; M Pérez-de-Lis; B Gracia-Tello; NT Samaniego; A Sisó-Almirall
    • الموضوع:
      Neurosarcoidosis
    • الموضوع:
      Date Created: 20210703 Date Completed: 20211105 Latest Revision: 20211105
    • الموضوع:
      20250114
    • الرقم المعرف:
      PMC8253777
    • الرقم المعرف:
      10.1038/s41598-021-92967-6
    • الرقم المعرف:
      34215779